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High risk for virus-induced asthma exacerbations in children is associated with an IRF7lo
immunophenotype, but the underlying mechanisms are unclear. Here, we applied a
Systems Biology approach to an animal model comprising rat strains manifesting high
(BN) versus low susceptibility (PVG) to experimental asthma, induced by virus/allergen
coexposure, to elucidate the mechanism(s)-of-action of the high-risk asthma
immunophenotype. We also investigated potential risk mitigation via pretreatment with
the immune training agent OM-85. Virus/allergen coexposure in low-risk PVG rats resulted
in rapid and transient airways inﬂammation alongside IRF7 gene network formation. In
contrast, responses in high-risk BN rats were characterized by severe airways eosinophilia
and exaggerated proinﬂammatory responses that failed to resolve, and complete absence
of IRF7 gene networks. OM-85 had more profound effects in high-risk BN rats, inducing
immune-related gene expression changes in lung at baseline and reducing exaggerated
airway inﬂammatory responses to virus/allergen coexposure. In low-risk PVG rats, OM-85
boosted IRF7 gene networks in the lung but did not alter baseline gene expression or
cellular inﬂux. Distinct IRF7-associated asthma risk immunophenotypes have
dichotomous responses to virus/allergen coexposure and respond differentially to OM85 pretreatment. Extrapolating to humans, our ﬁndings suggest that the beneﬁcial effects
OM-85 pretreatment may preferentially target those in high-risk subgroups.
Keywords: asthma exacerbation, rhinovirus, allergen, immunomodulation, IRF7, systems biology

INTRODUCTION
Rhinovirus infections are important triggers of severe asthma exacerbations among children (1, 2),
in particular those who are sensitized to perennial aeroallergens (3). Very few treatment options
exist, and drug development programs to redress this deﬁciency are currently stalled because the
underlying immunobiology is incompletely understood (2). To address this issue, we previously
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employed gene expression proﬁling to elucidate upper airway
responses in children who present to emergency departments
with severe exacerbations of asthma or wheeze. We found that
the response patterns were heterogeneous and could be divided
into IRF7hi versus IRF7lo immunophenotypes (4). IRF7hi
children were characterized by upregulation of IRF7/antiviral
response gene networks, whereas responses in IRF7lo children
lacked a corresponding antiviral signature, and instead
upregulated genes associated with cytokine and growth factor
signaling pathways (e.g. CSF3, EGF, IL-4R, IL-6, IL-10, TGFb).
Moreover, expression of the IRF7lo immunophenotype was
associated with more pr olonged symptoms d ur ing
exacerbations and shorter intervals between exacerbation
events (4).
In parallel to our studies in children we developed a rat model
of respiratory viral infection (5) employing attenuated
mengovirus as an alternative to human rhinovirus (6). The
approach entailed a comparison of BN and PVG rats, which
are respectively characterized by high versus low susceptibility
to chronic, allergen-driven type 2 (T2)-associated airways
inﬂammation. In a preliminary study focusing on
bronchoalveolar lavage (BAL) we found that naïve PVG and
BN rats elicit dichotomous responses to infection mirroring to
some extent the IRF7hi (PVG) and IRF7lo (BN) phenotypes we
observed in children. PVG rats upregulated the expression of
type I interferon-related pathways (Mx1, ISG15, IRF7, CXCL10)
and lacked markers of T2 inﬂammation. In contrast, BN rats
upregulated markers of T2 inﬂammation (IL-25, IL-33, ARG1)
and lacked a type I interferon signature. Importantly,
sensitization of the animals followed by virus/allergen
coexposure unleashed a severe airways inﬂammatory response,
which was dominated by eosinophils and orders of magnitude
higher in BN versus PVG rats even though viral loads were
comparable (5). We also investigated the impact of the timing of
virus/allergen coexposure on ensuing airways inﬂammation, and
we found that allergen exposure within 24 hours of viral
challenge resulted in maximally severe airways inﬂammation.
In the present study we have extended these investigations to
encompass comprehensive systems-level analyses of underlying
gene coexpression networks in lung and bone marrow tissues,
and sought ﬁrstly to elucidate the molecular basis for these
apparent differences in IRF7-related response proﬁles following
virus/allergen co-exposure in PVG versus BN rats, and secondly
to test the hypothesis that the asthma risk-associated IRF7lo
immunophenotype can be reprogrammed via pretreatment with
the immune training agent OM-85 to increase resistance to
virus/aeroallergen challenge.

male rats were utilized for all experiments. All animal
experiments were formally approved by the Telethon Kids
Institute Animal Ethics Committee, which operates under
guidelines developed by the National Health and Medical
Research Council of Australia for the care and use of animals
in scientiﬁc research (Ethic approval number AEC320).

Viral Model of Experimental Asthma
The model employs BN and PVG rats, previously shown by us to
exhibit respectively high versus low susceptibility to aeroallergeninduced airways inﬂammation (7), mimicking the human atopic/
non-atopic dichotomy. In follow-up studies the two strains were
shown to demonstrate correspondingly disparate levels of
susceptibility to severe airways inﬂammation triggered by
respiratory viral infection (5), which in the high-susceptibility
BN strain was further ampliﬁed by co-exposure to aeroallergen.
In the present experiments rats from both strains were sensitized
with 0.1mg ovalbumin (OVA)/500 ml Alum 14 days prior to
infection with attenuated mengovirus (vMC0), followed by
aerosol challenge (Ultraneb; DeVilbiss, Somerset, PA, USA)
with 1% OVA (Sigma Aldrich, St Louis, MO, USA) for 30
minutes at 1 day-post-infection (D). vMC0 was prepared as
previously described (6, 8) and rats were inoculated via
intranasal administration with 100 ml of 107 plaque-forming
units (PFU) of vMC0 (9). The inﬂammatory response was
assessed at D1, 2 and 9 by bronchoalveolar lavage (BAL) with
8 mL GKN (11mM; glucose, 5.5mM; KCl, 137mM; NaCl, 25mM;
Na2HPO4) + 5% FCS. Cell types were identiﬁed using DiffQuick staining of cytocentrifuged samples.

OM-85 Pretreatment
OM-85 (OM Pharma; Geneva, Switzerland) is an endotoxin-low
lyophilized extract containing multiple Toll-like receptor (TLR)
ligands derived from 8 major bacterial pathogens (Haemophilus
inﬂuenzae, Streptococcus pneumoniae, Streptococcus pyogenes,
Streptococcus viridans, Klebsiella pneumoniae, Klebsiella
ozaenae, Staphylococcus aureus, and Neisseria catarrhalis)
frequently associated with respiratory tract infections. OM-85
(single-batch) was administered orally via pipette at a dose of
40mg/kg body weight in PBS per day from 7 days after
sensitization until infection. This daily dose rate is 10-fold
lower than that used in the majority of previous animal model
studies carried out by our group and others.

Single-Cell Suspension Preparation
Single-cell suspensions of lungs and airway draining lymph
nodes were prepared by enzymatic digestion as previously
described (10). Peripheral blood was harvested by cardiac
puncture and mixed with heparin and mononuclear cells
(PBMC) were isolated using Histopaque (Sigma-Aldrich)
gradient enrichment per the manufacturer’s instructions. Cells
were resuspended in PBS with 0.1% Bovine Serum Albumin
(BSA). Bone marrow cells (BM) were harvested from tibia bones
via ﬂushing with 10 ml GKN + 5% FCS as previously
described (11).

MATERIALS AND METHODS
Animals
Brown Norway (BN) and Piebald Virol Glaxo (PVG) rats were
bred in-house at the Telethon Kids Institute (Perth, Australia)
under speciﬁed-pathogen-free conditions, with food and water
ad libitum and a 12 h light/dark cycle. Eight- to twelve-week-old
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a variance stabilizing transformation to normalize the data,
(ii) ﬁltered out genes expressed at a low level (only those with at
least 10 counts per sample were retained), (iii) removed genes
without an ofﬁcial Rat Genome Database symbol and (iv) removed
genes with low variability by applying the varianceBasedﬁlter()
function within the Differentially Coexpressed Gene/Link (DCGL)
package (19) (signiﬁcance threshold set to 0.05). The Gene Ontology
Consortium database was used to identify over-represented
biological processes and molecular functions associated with the
differentially expressed genes and network modules, using Fisher’s
exact tests and Bonferroni-corrected p-values; those <0.05 were
considered signiﬁcant (20, 21). Protein-protein interaction networks
were constructed for network modules of interest using mouse
orthologs [sourced from the Mouse Genome Database (22)] and
Network Analyst (v3.0) (23). Here, the STRING interaction
database (v10) (22) was used with default settings for other
parameters. Network type was set to “minimum” to focus on key
connectivities and reduce the number of ﬁrst-order neighbours.

Flow Cytometry
Single-cell suspensions of lungs, lymph node, PBMC and BM
were used for immunostaining using CD45, RT1b, CD3, CD161,
CD11b, CD4, CD8, CD127, CD25, CD43, CD172a, CD278,
CD45R (BD Pharmingen, San Jose, CA, USA; eBiosciences,
San Diego, CA, USA; BioLegend, San Diego, CA, USA;
Miltenyi Biotec, Bergisch‐Gladbach, Germany; Bioss, Woburn,
MA, USA; Abcam, Cambridge, UK; R&D Systems, Minneapolis,
MN, USA). Intracellular FoxP3 staining was conducted using the
eBiosciences FoxP3 intracellular staining buffer set. Data were
collected on a four-laser LSRFortessa (BD Biosciences) and
analyzed using FlowJo software (Version 10.0.7, Tree Star,
Sanford, CA, USA). See supplementary Figure S1 in the
Online Repository for complete gating strategy.

RNA Isolation and Sequencing
BM and lung tissue were resuspended in RNAlater (Ambion, Life
Technologies, Mulgrave, VIC, Australia) and frozen at -80°C.
Total RNA was extracted with TRIzol (Ambion) followed by
RNAeasy (Qiagen Gmbh, Hilden, Germany). Total RNA
libraries were prepared using TruSeq Stranded mRNA Library
Prep Kit (Illumina Inc, San Diego, CA) and sequenced by the
Australian Genome Research Facility (Illumina HiSeq2500, 50bp
single-end reads, v4 chemistry). On average, ~46 million reads
were generated per sample. The raw sequencing data are
available from GEO (GSE157441).

Microbiome Analysis
Fecal pellets were collected fresh for each rat (weighing on average
200 mg) and then stored at -80°C. DNA was extracted using the
QIAamp PowerFecal DNA kit (Qiagen, Hilden, Germany) with the
addition of mechanical lysis for 2 x 30s on a TissueLyser II (Qiagen,
Hilden, Germany). Extractions were automated using a QIAcube
Connect (Qiagen, Hilden, Germany) following the manufacturer’s
instructions. DNA concentrations were estimated using the
QIAxpert System (Qiagen, Hilden, Germany). PCR inhibitors
were assessed by a three-point dilution of each sample prior to
the amplicon PCR using quantitative polymerase chain reaction
(qPCR) with identical cycling conditions and primers as for
amplicon PCR. The amplicon PCR was performed using the
highest concentration of DNA showing no presence of inhibitors
for each sample with the V4 primers (515F and 806R) labelled with
unique dual barcodes for each sample, followed by PCR-free ligation
of sequence adapters. The MiSeq sequencing set-up was carried out
as per the manufacturers protocol. The amplicon library was
bidirectionally sequenced using a 500-cycle V2 reagent kit and a
V2 Standard ﬂow cell (Illumina, USA). Sequence read quality was
initially assessed with FastQC before demultiplexing and
preprocessing by GHAPv2, an in-house tool. Cutadapt (24) was
used for removal of all non-biological sequences before DADA (25)
was used for quality ﬁltering, error correction, amplicon sequence
variants (ASVs) picking. For this study the forward sequences were
trimmed at 180 bp and the reverse at 155 bp to maintain a constant
read quality of >30 and the overlapping region between the two
reads were >80 bp. A trained naïve bayes classiﬁer (RDP) (26) then
assign nomenclature to ASVs against the curated Genome
Taxonomy Database (27). Following assignment, decontamination
was performed with decontam (28) removing sequences not present
in minimum 4 samples with a minimum of 10 reads.

RNA-Seq Data Analysis
Read libraries were quality assessed using FastQC (12) (v0.11.3) and
mapped to the rat genome (rn6) using HISAT2 (13) (v2.0.4). Genelevel quantitation (counts) of aligned reads was performed using
SummerizeOverlaps (14), and post-alignment quality control was
performed using SAMStat (15) (v1.5.2). All downstream analyses
unless otherwise speciﬁed were performed in the R environment for
statistical computing (v3.5.1). Sample QC was performed by
examining relative log expression, density plots and principal
component analysis, and one outlier (with low RNA quality) was
removed from further analyses. Differentially expressed genes were
identiﬁed between experimental groups (within tissues) using
DESeq2 (16), following minimal gene ﬁltering to remove genes
with a summarized count of zero or one. Molecular drivers of the
differentially expressed genes were identiﬁed using upstream
regulator analysis (Ingenuity Systems) (17). Results were ﬁltered
to remove chemicals and drugs, to focus on biological mechanisms.
Activation Z-scores were calculated for each molecular driver by
comparing their known effect on downstream targets with observed
changes in gene expression; activation Z-scores ≥ 2 or ≤ -2 were
considered activated or inhibited, respectively. P-values derived
from DESeq2 and upstream regulator analysis were adjusted for
multiple comparisons using the Benjamini-Hochberg method;
those <0.05 were considered signiﬁcant. The weighted gene coexpression network analysis (WGCNA) (18) algorithm was used to
construct signed networks for lung and bone marrow samples
separately, with further separation by animal strain; resulting in
four distinct networks. To prepare data for WGCNA, we (i) applied
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Statistical analyses were performed using GraphPad Prism
software (V8, La Jolla California USA). Details are described
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within ﬁgure legends; P-values <0.05 were considered signiﬁcant.
Microbial analysis was conducted using Primer7 with
Permanova+ (PRIMER-e, Quest Research Limited, NZ). At the
phylum and genus level, relative abundance data were square
root transformed, prior to the calculation of a Bray-Curtis
dissimilarity matrix. Principal coordinates analysis was used to
examine possible differences or separations among the groups
visually at the 3-D level. This was followed by multivariate
analysis using PERMANOVA+ to statistically assess differences
between groups and changes over time. The model used for this
analysis was a 3-factor model, with group (PVG or BN), rats ID
(nested within group) and time point. Test of individual
phyla or genera differences between groups were also done
using PERMANOVA+.

pathways analysis demonstrated that the modules were enriched
for speciﬁc biological functions (Figures 2A, B). To determine if
the modules were preserved between strains, we calculated
module preservation statistics, and compared ranked
expression and ranked connectivity patterns in PVG versus BN
(Table S1 and Figure 3). We found that two PVG-speciﬁc lung
modules had markedly different connectivity patterns in BN rats:
an interferon/antiviral response module and a metabolic
regulation module. Reconstruction of the interferon/antiviral
response module using experimentally supported molecular
interactions from the Ingenuity Systems KnowledgeBase in
combination with Upstream Regulator Analysis demonstrated
that Irf7 is predicted to function as a hub and key driver of this
module (Figures 3A, E). Similar reconstruction of the metabolic
regulation module using InnateDB revealed several members of
the circadian clock as hub genes (Clock, Per1, Per3; Figure S2 in
the Online Repository), and core regulators of mitochondrial
homeostasis among the top predicted molecular drivers (Dap3,
Lrpprc, Nsun3, Sirt3; Figure 3B). We also identiﬁed one BN lung
module associated with airways remodeling with markedly
different connectivity patterns in PVG, the expression of which
increased with coexposure to virus/allergen and peaked at day
nine post-infection (Figure 2B). Transforming growth factor
beta 1(Tgfb1) was the top predicted driver for this module
(Figure 3D), and several collagen genes were among the top
hubs (Col1a1, Col3a1, Col1a2, Col5a1; Figure 3F). We next
examined network topology heatmaps for the three lung
modules of interest, and found that genes from the PVGspeciﬁc Irf7/antiviral and metabolic regulation modules failed
to form cohesive networks in BN lung (Figure S3). Conversely,
the BN-speciﬁc lung remodeling/Tgfb1 module did not form a
cohesive unit in PVG rats.
WGCNA analysis of gene expression patterns in bone
marrow cells revealed thirteen functional modules in PVG rats,
and nine in BN rats (Figures 2C, D). Again, we identiﬁed one
PVG-speciﬁc network module associated with Irf7/antiviral
responses (Figures 3C, S4 in the Online Repository). As
observed in lung tissue, the network connectivity patterns for
this Irf7 module in PVG bone marrow module were discordant
between BN and PVG rats (Figures 3C, S3 in the Online
Repository). All other bone marrow modules were preserved
between strains (Table S2 in the Online Repository). In
summary, our ﬁndings demonstrate that cohesive Irf7/antiviral
gene networks are present in PVG lung and bone marrow but are
absent from these tissues in BN rats. In contrast, only BN rats
exhibit a dedicated lung network module associated with
remodeling/Tgfb1 signaling, and peak expression of this module
was observed on day 9. This further supports that PVG mirrors
IRF7hi responders, whereas BN resemble IRF7lo responders.

Study Approval
All experiments were performed under guidelines from the
National Health and Medical Research Council of Australia
and approval of the institutional Animal Ethics Committee.

RESULTS
Sensitized PVG and BN Rats Exhibit
Dichotomous Responses to
Virus/Allergen Coexposure
We ﬁrst aimed to characterize responses to virus/aeroallergen
coexposure in PVG and BN rats across time through a
comprehensive systems biology approach. Figure 1A presents
an overview of the model and all analyses performed. Assessment
of airways inﬂammation highlighted two key features that
distinguish PVG from BN rats. First, the acute (day 1; D1)
inﬂammatory response to virus in PVG rats was dominated by
neutrophil inﬂux in BAL, in contrast to the acute eosinophilic
response observed in BN rats (Figure 1B). Neutrophil
recruitment was however observed in BN rats following virus/
allergen coexposure, to levels consistent with PVG rats peaking
at day 2 (D2). Second, BN rats exhibited marked eosinophilia at
all time points, while PVG rats displayed transient eosinophilia.
Importantly, BAL eosinophilia in BN rats remained signiﬁcantly
elevated at day 9 (D9), demonstrating incomplete resolution of
T2 inﬂammation.

PVG and BN Rats Mobilize Distinct
Gene Network Patterns in the Lung
and Bone Marrow
Next, we analyzed global patterns of gene expression in the lung
to provide a deeper understanding of responses to virus/allergen
coexposure. Given accumulating evidence that atopic asthma
exacerbations are in part mediated through a lung/bone marrow
axis (29), we analyzed gene expression patterns in bone marrow
in parallel. We generated tissue-speciﬁc weighted co-expression
gene networks for PVG and BN rats to reconstruct the global
architecture and functional organization of the gene expression
program occurring within each strain. Using this approach, we
identiﬁed seven modules in PVG lung, and nine in BN lung, and
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Virus/Allergen Coexposure Induces
Exaggerated and Sustained
Transcriptional Changes in the
Lungs of BN Rats
The above analyses provide a global view of the functional
organization and connectivity structure of the gene expression
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FIGURE 1 | PVG and BN rats exhibit distinct cellular proﬁles of airways inﬂammation following virus/allergen coexposure. (A) PVG and BN rats were sensitized with
OVA/Alum. Seven days later, rats from each strain were randomly allocated to experimental groups receiving OM-85 for seven consecutive days or nil treatment. All
animals apart from a baseline control group (Day 0) were then infected with attenuated mengovirus and challenged with OVA 24hr later. Tissues were harvested at
baseline, one day post-infection representing the response to virus alone, and days two and nine post-infection representing the response to virus and allergen coexposure. The analyses performed included i) differential cell counts on BAL ﬂuid, ii) RNA-Seq on homogenized lung and bone marrow, iii) 14-colour ﬂow cytometry
on single-cell suspensions of PBMC, airway draining lymph node, bone marrow and peripheral lung tissue, and iv) assessment of the gut microbiome (prior to virus/
allergen coexposure only). Figure created with BioRender.com (B) Enumeration of total cells, eosinophils, neutrophils, lymphocytes, and macrophages in BAL via
differential cell counts at baseline and following viral/OVA challenge in PVG and BN rats without OM-85 treatment. Data from more than 3 independent experiments,
n = 6–8 per group. Two-way ANOVA with Tukey’s multiple comparisons test were performed to compare data within and between strains. *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001. BAL, bronchoalveolar lavage, D0: day 0, D1: day 1, D2: day 2, D9: day 9.

comparisons), and more than 200 differentially expressed genes
in PVG (79 and 153 differentially expressed genes at day one and
nine post-infection, respectively; Tables S3, S4 in the Online
Repository). The day nine changes in PVG bone marrow were
associated with decreased expression of genes involved in
ribosomal activity, and increased expression of genes involved
in metabolic pathways (Figure S5 in the Online Repository).

program in PVG and BN in the context of virus/allergen
coexposure. We next aimed to identify sets of genes that were
differentially expressed over time in the respective responses
and identify underlying molecular drivers. The greatest
transcriptional changes were observed in the lungs of both
strains following virus/allergen coexposure on day 2
(Figure 4A). However, the BN-response was much more
intense than that of PVG rats, even at day 9 post-infection.
Employing Upstream Regulator Analysis (17) we demonstrated
that the peak response to virus/allergen coexposure in both
strains was mediated by canonical drivers of inﬂammation
(Tnf, Il1b, Ifng, Il6) and T2 pathways (Il4, Il5), but that these
pathways were exaggerated in BN rats (Figures 4A, B). Indeed,
Il5 was the top ranked regulator in terms of activation Z-score,
and the expression of most genes downstream of Il5 was elevated
in BN relative to PVG on day 2 (Figure 4C). In addition,
activation of growth factor signaling (Tgfb1, Erbb2, Vegf, Hgf)
was a distinct feature of the BN lung response, with Tgfb1 still the
predominant driver at day nine (Figure 4B). Interestingly,
analysis of bone marrow revealed limited changes in gene
expression in BN (<7 differentially expressed genes across all

Frontiers in Immunology | www.frontiersin.org

PVG and BN Rats Display Differential
Tissue Recruitment of Innate Lymphoid
Cells, Dendritic Cells and Neutrophils
Following Virus and Allergen Exposure
We employed ﬂow cytometry to examine local and systemic
changes in immune cell populations (Figure S1). The PVG
response to virus/allergen coexposure was characterized by
early peaks in plasmacytoid dendritic cell (pDC) inﬂux in the
airway draining lymph node, and transient increases in type 2
innate lymphoid cells (ILC2), neutrophils and CD4conventional dendritic cells (cDCs) which all peaked at day
two post-infection in the airway draining lymph node and/or
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A

B

C

D

FIGURE 2 | Overview of the global gene networks operating in lung and bone marrow of PVG and BN rats. Separate tissue-speciﬁc weighted co-expression gene
networks were generated for PVG and BN lung (A, B) and bone marrow (C, D). Dendrograms are shown for each network, where distinct color blocks represent
separate functional modules (clusters of correlated or co-expressed genes). Associated module functions are described for each network and the summarized
expression of each module (eigengene value) is shown over the course of viral infection and allergen challenge. Modules relating to immune and metabolic pathways
are separated (right) from all others (left). Arrows highlight four modules speciﬁc to PVG or BN rats. Sample sizes for network construction: BN bone marrow n = 47,
PVG bone marrow n = 49, BN lung n = 48, PVG lung n = 47.

lung (Figures 5, S6). In contrast, the BN response was skewed
towards expansion of ILC populations, where ILC2 frequencies
in the lung and airway draining lymph node progressively
increased to reach their highest levels on day nine postinfection, concurrent with elevated bone marrow ILC1 cells
(Figures 5, S6). Further, BN rats displayed delayed pDC
recruitment, and a sustained increase in neutrophils within the
periphery that was not observed in PVG rats.

was attributed to strain alone. Differential gene expression
analysis identiﬁed 1078, and 924 genes with an absolute foldchange in expression >2 between PVG and BN rats in the lung
and bone marrow, respectively (Tables S5, S6 in the Online
Repository). Genes with increased expression in BN rats were
enriched for several immune response pathways in both lung and
bone marrow (Figure S7A in the Online Repository).
Interestingly, we also observed a relative dampening of viraldefense pathways in the bone marrow of BN rats (Figure S7B in
the Online Repository). These differences were predicted to be
driven by activation of several molecules relating to
maintenance/activation of myeloid cells in the lung (Gata2,
Mif, MyD88, Csf2), alongside the hallmark T2 cytokine Il13
(Figure 6B). In contrast, the differences in bone marrow
proﬁles were characterized by activation of Stat6 and Trem1
signaling and inhibition of viral response pathway regulators
(Ifnb1 and Ifnl1, Figure 6B).

Sensitized PVG and BN Rats Exhibit
Differences in Cellular and Molecular
Proﬁles at Baseline
To better understand the mechanisms contributing to the
divergent responses to virus/allergen coexposure between PVG
and BN rats, we compared their cellular and molecular proﬁles
across tissues at baseline. Overall, PVG rats had higher
proportions of natural killer cells (NK) and CD8 T cells in
multiple tissues, mirrored by decreased proportions of Tregulatory cells (Figure 6A). In BN rats, ILC populations were
elevated compared to PVG and skewed towards ILC1/3,
particularly in the lymph nodes. Stark differences between
strains were also evident at the molecular level. Principal
component analysis revealed distinct gene expression proﬁles
between PVG and BN rats at baseline in both lung and bone
marrow (Figure 6B), where 60–65% of transcriptional variation
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OM-85 Pretreatment Has Distinct
Effects on PVG and BN Responses to
Virus and Allergen
The immunomodulator OM-85 shows promise as a safe and
effective preventative treatment for protection against airways
inﬂammation triggered by a diverse range of stimuli (30), but has
not been studied in the context of IRF7-associated
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FIGURE 3 | Functional gene networks unique to either PVG or BN rats. The four gene network modules unique to either PVG lung (A, B), PVG bone marrow
(C) or BN lung (D). Over-represented biological pathways are shown for each module, the red line at 1.3 represents the threshold for signiﬁcance equivalent to a
Bonferroni-corrected p-value <0.05. For each network module, ranks of gene connectivity (reﬂecting the relative importance of that gene within the network module)
and gene expression were calculated for both PVG and BN: correlation plots between rat strains are shown. The top ten predicted molecular drivers are shown for
each module, where the dashed line represented the threshold for signiﬁcance. Prior knowledge network reconstructions are shown for the PVG lung black module
(E) and the BN lung green module (F) where red and green coloring indicate increased and decreased expression respectively on day 2 (for E) and day 9 (for F)
relative to day 0. Sample sizes for network construction: BN bone marrow n = 47, PVG bone marrow n = 49, BN lung n = 48, PVG lung n = 47.
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FIGURE 4 | Distinct transcriptional changes occur in lungs of PVG and BN rats following viral- and allergen-exposure. (A) Heatmap visualizing the union of
differentially expressed genes induced following viral infection and OVA challenge within either PVG or BN rats; genes ranked using unsupervised hierarchical
clustering. Red and blue coloring indicate relative increased or decreased expression for each gene, respectively. Data from more than 3 independent experiments
with n=6 per time point. (B) The top twenty predicted upstream transcriptional regulators of the differentially expressed genes at day two and nine. Red and blue
indicate predicted activation (Z-score > 2) and inhibition (Z-score < -2), respectively. P-values were adjusted for multiple comparisons using the Benjamini-Hochberg
method; the dashed line at -1.3 represents the threshold for signiﬁcance. Activation Z-scores for TGFB1 and ERBB2 are compared between strains over the course
of infection and allergen challenge. (C) Network wiring diagram for IL5 where nodes are colored based on comparison between BN and PVG day 2 responses; red
and green indicate increased and decreased expression in BN relative to PVG on day 2, respectively.
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FIGURE 5 | PVG and BN rats display differential cellular recruitment into tissues following challenge with virus and allergen. Flow cytometric analysis of lung, bone
marrow, airway draining lymph node (ADLN), and PBMC over the course of viral infection and allergen challenge. Data are presented as the percentage of CD45+
cells (mean ± standard error of the mean) normalized to Day 0, from more than 3 independent experiments with n = 4-6 per strain, tissue, and time point. One-way
ANOVA with Dunnett’s multiple comparisons test was performed to determine differences at each time point relative to baseline, within PVG and BN separately.
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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FIGURE 6 | Cellular and molecular differences are evident between sensitized PVG and BN rats. (A) Flow cytometric analysis of lung, bone marrow (BM), airway
draining lymph node (ADLN), and PBMC revealed differences in the proportions of several immune cell types at baseline (day 0, untreated) between strains. Data
from more than 2 independent experiments with n = 4 per strain, T-tests comparing PVG (yellow) and BN (purple) rats were performed for each cell type within each
tissue; *p < 0.05, **p < 0.01, and ***p < 0.001. (B) Principal component analysis using the top 1000 variable genes across samples revealed distinct separation
between PVG and BN rats, in both tissues (Data from more than 2 independent experiments with n = 6 each). The top twenty predicted upstream transcriptional
regulators of the differentially expressed genes between PVG and BN rats are presented. Red and blue indicate predicted activation (Z-score > 2) and inhibition (Zscore < -2), respectively. P-values were adjusted for multiple comparisons using the Benjamini-Hochberg method. The dashed line at -1.3 represents the threshold
for signiﬁcance.
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relative abundance of Anaerotruncus and Dorea (Figures 8A, B).
Assessment of the microbiome in droppings following OM-85
pretreatment showed an overall convergence between PVG and
BN rats: several genera that were different at baseline between
strains including Prevotella, were similar post-treatment
(Figure 8A). Further, statistical assessment of the differences
between PVG and BN rats at the genus-level was no longer
signiﬁcant (p=0.105). There were, however, some new differences
in speciﬁc genera post-OM-85 preventative treatment including
Butyrivibrio (Figure 8C), while Dorea remained signiﬁcantly more
abundant in PVG rats regardless of OM-85 treatment (Figure 8B).
Within-strain analysis identiﬁed three genera signiﬁcantly altered in
PVG rats only following OM-85 pretreatment, while no treatmentassociated changes were speciﬁc to BN rats (Figure 8D).

immunophenotypic responses to virus/allergen coexposure.
Here, we evaluated OM-85 pretreatment as a potential
therapeutic strategy to attenuate airways inﬂammation in PVG
and BN rats. The data showed that OM-85 had no impact on
neutrophil or eosinophil inﬂux in PVG rats over the time-course
of virus/aeroallergen coexposure (Figure 7A). In BN rats
however, OM-85 signiﬁcantly boosted the acute neutrophilic
response to virus on day 1, concomitant with a reduction of
eosinophilia on days 2 and 9 (Figure 7A). Consistent with the
BAL data, OM-85 pretreatment was associated with signiﬁcant
gene expression changes in baseline lung tissue from BN rats
(178 differentially expressed genes; Table S7 in the Online
Repository) but had close to no effect on PVG lung tissue
(only 2 differentially expressed genes). The most signiﬁcant
over-represented biological processes associated with OM-85mediated molecular changes in BN lung were associated with
innate and adaptive immunity, in particular increased expression
of Egr1, Cxcl9, and Il12rb1, which play key roles in antiviral
defense (Tables S7, S8). In contrast, assessment of OM-85
pretreatment effects in bone marrow on the basis of global
gene expression revealed only minor changes in both PVG and
BN rats. As a complimentary analysis, we looked at the effect of
OM-85 on the expression of our deﬁned network modules in
lung and bone marrow. Here, OM-85 pretreatment was
associated with increased eigengene values (representing
summarized gene expression) for the PVG lung Irf7/antiviral
and metabolic regulation modules (day two and nine postinfection, respectively), and reduced expression of the BN
module related to lung development at day nine post-infection
(Figure 7B). We also examined the effect on OM-85 on the
expression of selected IRF7 pathway genes in whole lung, and
although the ﬁndings were mostly not signiﬁcant, there was a
trend for stronger effects of OM-85 in BN compared to PVG
particular at D2 post infection (Figure S8). OM-85 pretreatment
had no signiﬁcant impact on the expression of bone marrow
network modules in either strain. Finally, we observed cellular
changes associated with OM-85 in all tissues, predominantly in
BN rats (Figure 7C). These changes included alterations to the B
cell compartment in PBMC, airway draining lymph node and
bone marrow, and shifts in DC/ILC populations in PBMC, lung
and lymph node.

DISCUSSION
Inﬂammatory response proﬁles amongst children during severe
asthma exacerbations are characterized by IRF7hi and IRF7lo
immunophenotypes; the latter phenotype is associated with
prolonged symptoms and shorter intervals between
exacerbation events, however the immunological and
molecular features that underpin these dichotomous proﬁles
are not well understood (4). The sub-group of children at
highest risk of severe exacerbations are atopics who are
sensitized to perennial (in particular indoor) aeroallergens (1,
2, 29, 32). Concomitant exposure to the latter during respiratory
viral infections is virtually unavoidable. To gain new insight into
the contribution of variations in IRF7-associated
immunophenotypes in this context, we utilized an
experimental rat model of virus/allergen co-exposure using two
strains that mirror these dichotomous IRF7 phenotypes and
characterized each employing a comprehensive systems biology
approach. IRF7 gene networks were readily identiﬁed in the lung
and bone marrow of PVG rats following exposure, yet were
completely absent from these compartments in BN rats.
Moreover, we observed divergent patterns of airways
inﬂammation between strains. Early neutrophil recruitment in
BAL and plasmacytoid dendritic cells in airway draining lymph
nodes were unique to PVG rats, while BN rats displayed
persistent eosinophilic inﬂammation in BAL concomitant with
progressive recruitment of ILC2 cells in the lung/airway. Further,
BN rats displayed exaggerated airways inﬂammation through
upregulation of proinﬂammatory responses (e.g. TNF, IL-1B,
IFNG, IL-4, IL-5), and genes involved in TGFb signaling and
airways remodeling. Importantly, we also observed differences
between PVG and BN rats in terms of their response to
immunomodulating therapy with OM-85. In PVG rats, OM-85
pretreatment boosted the overall expression of lung IRF7 gene
networks but did not alter BAL airways inﬂammation. In
contrast, OM-85 pretreatment increased neutrophilic airways
inﬂammation to infection and decreased eosinophilic responses
to virus/allergen coexposure in BN. Finally, microbiome proﬁles
at baseline were distinct in PVG and BN rats, and this was
mitigated in part by OM-85 preventative treatment. In summary,

PVG and BN Rats Have Distinct Gut
Microbiome Proﬁles Which Are Modiﬁed
by OM-85 Pretreatment
Finally, in view of the growing evidence of a role for the
microbiome in regulating airways inﬂammation (31), we
conducted an exploratory analysis of potential effects of OM85 preventative treatment on respective gut microbiome proﬁles
in the two strains. At the phylum level pre-treatment, both
strains were dominated by Bacteroidetes and Firmicutes (Table
S9 in the Online Repository), however the relative abundance of
Bacteroidetes was signiﬁcantly higher in BN rats (mean ± SEM of
69 ± 3% vs 56 ± 4%, p=0.0108). In addition, the overall
composition of the microbiota at the genus level was different
between strains (p=0.0467), including a higher relative
abundance of Prevotella in BN rats, paralleled by a lower
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FIGURE 7 | The effect of OM-85 on responses to virus and allergen. (A) Enumeration of eosinophils and neutrophils in BAL via differential cell counts at baseline,
and following the course of viral infection and allergen challenge in PVG and BN rats with and without OM-85 pretreatment. Data from more than 3 independent
experiments with n = 5-6 per strain, treatment group and time point. (B) The effect of OM-85 pretreatment on gene networks within lung tissue, presented as violin
plots of summarized gene expression (eigengene values). Data from more than 3 independent experiments with n = 6 per strain and treatment group. (C) Flow
cytometric analysis of lung, PBMC, airway draining lymph node (ADLN) and bone marrow over the course of viral infection and allergen challenge with and without
OM-85 treatment. Data are presented as mean ± standard error of the mean, from more than 3 independent experiments with n = 3-7. Statistical comparisons
between OM(pos) and OM(neg) samples were performed using one-way ANOVA with Sidak’s multiple comparisons tests in (A) and (C), and Mann-Whitney tests in
(B). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

and allergen in sensitised PVG rats. Extending our previous work
to comprehensive molecular characterisation of lung tissue we
identiﬁed a small (<100 genes) yet highly specialised gene
network associated with interferon signaling in PVG rats, with
IRF7 at its core. IRF7 is a transcription factor critical for type I
interferon production in response to viral infection, downstream
of viral-engagement with various pattern recognition receptors
(34), and is a major hub connecting molecular networks that are
induced in the respiratory tract during viral-induced asthma
exacerbations (35). The importance of IRF7-dependent
interferon production in anti-viral immunity has been
extensively validated, and is perhaps best exempliﬁed by
human and animal studies in which genetic IRF7 deﬁciencies
are associated with heightened susceptibility to severe
(respiratory) viral infections (36, 37). Moreover, PVG rats
displayed rapid expansion of pDCs in the airway draining
lymph nodes following viral infection. These cells are the most
potent producers of type I interferon, exhibit high constitutive
expression of IRF7 (38), and are responsible for 70–80% of the
gene expression program induced by human rhinovirus in

we have identiﬁed the immunological and molecular hallmarks
that underpin IRF7 phenotypes in an experimental rat model,
and further demonstrated that these phenotypes respond
differentially to OM-85 pretreatment. Our ﬁndings have
implications for the design of translational studies that employ
microbial products to reprogram innate immune responses for the
prevention of virus-induced exacerbation of allergic airways disease.
Upper airway gene expression proﬁling in both children and
adults with asthma demonstrate heterogenous interferon
responses during in vivo rhinovirus infection (4, 33), where
dampened or dysregulated expression of interferon genes is
inversely correlated with severity of clinical symptoms and
viral clearance. Here, we have used PVG and BN rats to model
these distinct immunophenotypes, allowing investigation beyond
the upper airway. Our previous comparisons between PVG and
BN rats in the setting of viral infection and/or allergen exposure
have focused on local immune responses in the airway and
associated mucosa (5, 7). Consistent with those studies, we report
rapid neutrophil recruitment to the airway alongside moderate
and self-resolving eosinophilia following challenge with virus

Frontiers in Immunology | www.frontiersin.org

12

July 2021 | Volume 12 | Article 699633

de Jong et al.

IRF7 Dependent Asthma Immunomodualtion

FIGURE 8 | Differences in the microbiome between PVG and BN rats at with and without OM-85 treatment. The effect of OM-85-pretreatment on the microbiome
at genus-level. Observed differences were either; evident at baseline (Day 0) without treatment, but no longer different between strains with OM-85 treatment (A),
evident between strains independent of OM-85 treatment (B), only evident between BN and PVG rats with OM-85 treatment (C), or evident within PVG rats when
comparing treatment groups (D). Results are presented as relative abundance; bars show median and upper quartile from more than 3 independent experiments
with n = 12 per group. NS, not signiﬁcant; *p < 0.05, **p < 0.01 and ***p < 0.001.

system may also contribute to exacerbated airways inﬂammation
and remodeling, given the inverse relationship between IRF7 and
IL-33 expression (key driver of type 2 inﬂammation) observed in
human airway cells in vitro (40) and ex vivo (4), and in animal
models (41). In this regard it is pertinent to note that while
expression of the human T2hi immunophenotype confers
markedly increased risk of atopic asthma as illustrated by
epidemiological ﬁndings demonstrating that whilst >80% of
asthmatic teenagers are atopic, <20% of teenagers sensitized to
aeroallergens actually develop clinically signiﬁcant airways
disease, suggesting that additional risk factor(s) must operate
in synergy with atopy to precipitate disease expression (42), and

PBMC (39). We observed conservation of the IRF7 gene network
in the bone marrow of PVG rats, and increased frequencies of
bone marrow pDCs two days post-viral infection, supporting an
active role for the bone marrow during direct environmental
insults to the airway. Remarkably, neither pDC mobilisation in
the airway or bone marrow, or formation of IRF7 gene networks
in these compartments were apparent in BN rats. While BN rats
are not IRF7 deﬁcient, they exhibit a complete breakdown in the
underlying molecular wiring of the IRF7 gene networks that in
contrast, form cohesively in PVG rats, suggesting dysregulation
of this pathway in BN rats. Failure to orchestrate a rapid immune
response via IRF7 following viral infection in a T2hi biased
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of which were over-expressed in the Amish (i.e. children with
low rates of allergies/asthma and high microbial exposures) (53).
We did not observe up-regulation of TNF (or associated innate
pathways) in either BN or PVG rats following OM-85 pretreatment.
As TNF production is triggered by LPS engagement with TLR4
(54), this discrepancy is likely explained by the fact that OM-85 is
an endotoxin low product (55), whereas dust from Amish homes
contained levels of endotoxin ~7 times higher than in Hutterite
homes (53). In our model, OM-85 pretreatment signiﬁcantly shifted
the proﬁle of airways inﬂammation in BN rats through dampening
eosinophilia and expression of gene networks involved in airways
remodelling, while boosting neutrophil recruitment. In contrast,
OM-85 pretreatment had no effect on the cellular composition of
BAL in PVG rats but did enhance overall expression of IRF7 and
metabolic gene networks in PVG lung. The contrasting effects of
OM-85 pretreatment in PVG versus BN rats suggests that the
protective effects of microbial products [as observed in children
raised in farming environments (56, 57)] may be inﬂuenced by
genetic background. The mechanism of action of OM-85 we
observed in this study is also consistent with ﬁndings in other
infection models in which OM-85 pretreatment attenuated LPSinduced inﬂammation (systemic and local) while preserving
interferon response pathways (58).
Interestingly, we also detected a molecular signature associated
with OM-85 pretreatment in BN lung at baseline, that was not
identiﬁed in PVG rats. This signature was associated with activation
of complement, B-cells, immunoglobulin activity and phagocytosis,
in line with early studies on the immunomodulatory properties of
OM-85 (59–62), and a more recent viral-challenge animal model
demonstrating activation of splenic B cells and production of antiviral antibodies (in serum and BAL) following oral administration
of OM-85 (63). The proposed mechanisms of action of oral OM-85
include activation of immune cells in gut- and mucosal-associated
lymphoid tissue (64) and in bone marrow (65), thus comparisons of
these tissues between PVG and BN rats post treatment would be of
interest in future studies. The fact that OM-85 pretreatment had a
more profound effect in BN rats broadly reﬂects the ﬁndings of a
recent phase IV clinical trial, where the greatest beneﬁt was seen in
children most vulnerable to respiratory tract infections (66).
Another potential mechanism by which OM-85 pretreatment
exerts effects on the immune response to virus and allergen is through
modulation of the gut microbiome, yet no studies to date have
investigated this issue. Here, we report an overall convergence in gut
microbiome proﬁles between PVG and BN rats following OM-85
pretreatment, whereas baseline analyses revealed signiﬁcantly higher
relative abundances of Bacteriodetes (including Prevotella) in BN rats
and enrichment of Firmicutes in PVG, echoing human nasal
microbiome proﬁles of subjects with exacerbated, and nonexacerbated asthma, respectively (67). Counterintuitively, all of the
statistically signiﬁcant OM-85-induced differences we observed
occurred in PVG rats, although the biological relevance of these
changes is uncertain, given the median magnitude of change was
roughly half a percent (or less) in terms of relative abundance.
Furthermore, other genera were not affected by OM-85 pretreatment:
Dorea remained under-represented in T2hi BN rats both pre- and
post-OM-85, consistent with other reports of reduced Dorea in stools

it is tempting to speculate that the IRF7lo immunophenotype
may play such a role.
Indeed, the response dynamics unique to BN rats reﬂect a
scenario of on-going eosinophilia and exacerbated airways
inﬂammation driven by growth factors, TGFb1 in particular.
TGFb1 signaling is mediated intracellularly via the phosphorylation
and subsequent nuclear translocation of SMAD2/3 transcription
factors (43), and both genome-wide association and epigenetic
studies have identiﬁed associations between components of the
TGFb1 signalling pathway and asthma risk (44, 45). Further,
TGFb1 was identiﬁed as a putative driver of the molecular
changes speciﬁc to IRF7lo viral asthma exacerbations (4), and
recent transcriptomic analyses of nasal epithelium conﬁrms a
SMAD3-centered molecular signature associated with both viral
and non-viral asthma exacerbations in children (46). We also
identiﬁed a gene network speciﬁc to BN lung that was associated
with airways remodeling, in which several collagen genes were
among the most highly interconnected hubs. Aberrant collagen
deposition is characteristic of airway remodelling in asthma (47),
and recent evidence directly implicates eosinophils in the
expression of collagen in airway smooth muscle via TGFb1
signalling in humans with allergic asthma (48), providing a
circuit connecting the features distinct to BN rats in our model.
In addition to the central role of TGFb in airways remodeling (49),
this multifunctional cytokine is required for the generation and
functional maintenance of ILC2 cells (50), which were progressively
recruited to the lung and airway draining lymph nodes in BN rats
but only transiently (and moderately) elevated in lungs of PVG rats.
ILC2 cells promote T2 inﬂammation and eosinophilia in the airway
(51), again showcasing the high-allergen-responder phenotype of
BN rats. Finally, a molecular signature associated with increased T2
signalling (driven by STAT6, a mediator of IL-4/IL-13 signaling)
and dampened interferon was evident in the bone marrow of BN
rats at baseline, mirrored by reduced proportions of cDCs and
increased CD4 T cells compared with PVG. Collectively, these
ﬁndings demonstrate an imbalance between interferons and T2
signalling between sensitised PVG and BN rats over the course of
viral infection provoked by allergen exposure and links the
immunological landscape of the bone marrow to airway
vulnerability in our model. Similar immunophenotypes
distinguished by the relative strength of T2 and type I interferon
signaling are evident in airway mucosa of children with acute viral
bronchiolitis (52), and are even predictive of exacerbation risk in
upper airway samples (46) highlighting the clinical relevance of
these observations.
Importantly, the differences we observed between PVG and
BN rats extended beyond their cellular and molecular proﬁles, to
include their response to OM-85 pretreatment. The rationale for
employing microbial products to attenuate asthma exacerbations
is derived from comparisons of children raised in traditional
farming environments, with similar genetic backgrounds,
lifestyles, and diets, but strikingly different rates of allergic
sensitisation and asthma (53). Notably, comparisons between
Amish and Hutterite farm children by Stein et al. identiﬁed IRF7
and TNF as key network hubs connecting differentially expressed
genes in peripheral blood cells between these populations, both
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of children with mite-sensitised rhinitis (68), and young adults with
food allergy and sensitisation (69). Our observation that orally
administered OM-85 had signiﬁcant effects on the lung
compartment in asthma-susceptible BN rats does suggest that
interactions between the gut and lung contribute to disease
expression and resolution. Indeed, Arrieta et al. identiﬁed four
bacterial genera that were associated with asthma risk in infants,
and conﬁrmed a causative role for these taxa in ameliorating airways
inﬂammation in an animal model (70). However, whether
compositional shifts in the gut microbiome following oral OM-85
are causative of downstream effects or merely associative, remains to
be determined.
We acknowledge that our study has limitations. First, molecular
assessment of lung and bone marrow was performed through bulk
RNA-Seq proﬁling, thus the levels of gene expression represent the
average across multiple different cell populations within each tissue,
obscuring the relative contributions of individual cell populations.
This limitation is partially overcome through comprehensive
cellular proﬁling of each tissue by ﬂow cytometry, and future
studies based on single-cell RNA-Seq technologies will provide a
deeper understanding of IRF7 immunophenotypes at single cell
resolution. Second, we have focused on characterising the molecular
and cellular hallmarks that underpin IRF7 immunophenotypes and
their response to OM-85 pretreatment to inform clinical and
translational studies, however, detailed mechanistic studies will be
required to dissect the precise molecular mechanisms that control
these phenotypes, including the speciﬁc function of IRF7 in the lung
versus bone marrow. Notwithstanding these limitations, our
ﬁndings demonstrate that the IRF7lo immunophenotype
markedly increases risk for severe airways inﬂammation to virus/
allergen coexposure, and moreover demonstrate that pretreatment
with OM-85 has potential to mitigate susceptibility to ensuing
airways inﬂammation by upregulation of T1-associated pathways
(Il12rb1, Cxcl9) and attenuation of T2 inﬂammation.
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